Andrews, J. D., Mancini, D. N., Singh, S. M., & Rodenhiser, D. I. J. H. M. G. (1996). Site and sequence specific DNA methylation in the neurofibromatosis (NF1) gene includes C5839T: The site of the recurrent substitution mutation in exon 31. Human Molecular Genetics, 5(4), 503–507.
Article CAS PubMed Google Scholar
Ars, E., Kruyer, H., Morell, M., Pros, E., Serra, E., Ravella, A., Estivill, X., & Lazaro, C. (2003). Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients. Journal of Medical Genetics, 40(6), e82–e82.
Article CAS PubMed PubMed Central Google Scholar
Assunto, A., Ferrara, U., De Luca, A., Pivonello, C., Lombardo, L., Piscitelli, A., Tortora, C., Pinna, V., Daniele, P., Pivonello, R. J. O. J., & o. R. D. (2019). Isoform-specific NF1 mRNA levels correlate with disease severity in neurofibromatosis type 1. Orphanet Journal of Rare Diseases, 14(1), 1–9.
Banck, M. S., Kanwar, R., Kulkarni, A. A., Boora, G. K., Metge, F., Kipp, B. R., Zhang, L., Thorland, E. C., Minn, K. T., & Tentu, R. (2013). The genomic landscape of small intestine neuroendocrine tumors. The Journal of Clinical Investigation, 123(6), 2502–2508.
Article CAS PubMed PubMed Central Google Scholar
Banerjee, S., Dai, Y., Liang, S., Chen, H., Wang, Y., Tang, L., Wu, J., & Huang, H. (2016). A novel mutation in NF1 is associated with diverse intra-familial phenotypic variation and astrocytoma in a Chinese family. Journal of Clinical Neuroscience, 31, 182–184.
Article CAS PubMed Google Scholar
Ben-Shachar, S., Dubov, T., Toledano-Alhadef, H., Mashiah, J., Sprecher, E., Constantini, S., Leshno, M., & Messiaen, L. M. (2017). Predicting neurofibromatosis type 1 risk among children with isolated café-au-lait macules. Journal of the American Academy of Dermatology, 76(6), 1077-1083. e1073.
Cali, F., Chiavetta, V., Ruggeri, G., Piccione, M., Selicorni, A., Palazzo, D., Bonsignore, M., Cereda, A., Elia, M., & Failla, P. (2017). Mutation spectrum of NF1 gene in Italian patients with neurofibromatosis type 1 using Ion Torrent PGM™ platform. European Journal of Medical Genetics, 60(2), 93–99.
Cao, Y., Gao, Z., Li, L., Jiang, X., Shan, A., Cai, J., Peng, Y., Li, Y., Jiang, X., & Huang, X. (2013). Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1. Nature Communications, 4(1), 2810.
Chai, P., Luo, Y., Zhou, C., Wang, Y., Fan, X., & Jia, R. J. B. M. G. (2019). Clinical characteristics and mutation spectrum of NF1 in 12 Chinese families with orbital/periorbital plexiform neurofibromatosis type 1. BMC Medical Genetics, 20, 1–9.
Chen, L., Xue, F., Xu, J., He, J., Fu, W., Zhang, Z., & Kang, Q. (2019). Five novel NF1 gene pathogenic variants in 10 different Chinese families with neurofibromatosis type 1. Molecular Genetics & Genomic Medicine, 7(9), e904.
Consoli, C., Moss, C., Green, S., Balderson, D., Cooper, D. N., Upadhyaya, M. J. J., & o. i. d. (2005). Gonosomal mosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1. The Journal of Investigative Dermatology, 125(3), 463–466.
Article CAS PubMed Google Scholar
Corsello, G., Antona, V., Serra, G., Zara, F., Giambrone, C., Lagalla, L., Piccione, M., Piro, E. J. I. J., & o. P. (2018). Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1. Italian Journal of Pediatrics, 44, 1–7.
Dalili, S., Hoseini Nouri, S. A., Bayat, R., Koohmanaee, S., Tabrizi, M., Zarkesh, M., Tarang, A., & Mahdieh, N. (2023). Neurofibromatosis-Noonan syndrome and growth deficiency in an Iranian girl due to a pathogenic variant in NF1 gene. Human Genomics, 17(1), 12. https://doi.org/10.1186/s40246-023-00460-0
Article CAS PubMed PubMed Central Google Scholar
De Schepper, S., Maertens, O., Callens, T., Naeyaert, J.-M., Lambert, J., & Messiaen, L. (2008). Somatic mutation analysis in NF1 café au lait spots reveals two NF1 hits in the melanocytes. Journal of Investigative Dermatology, 128(4), 1050–1053.
Deschamps, L., Dokmak, S., Guedj, N., Ruszniewki, P., Sauvanet, A., & Couvelard, A. (2010). Mixed endocrine somatostatinoma of the ampulla of vater associated with a neurofibromatosis type 1: A case report and review of the literature. Journal of the Pancreas, 11(1), 64–68.
Evans, D. G., Bowers, N., Burkitt-Wright, E., Miles, E., Garg, S., Scott-Kitching, V., Penman-Splitt, M., Dobbie, A., Howard, E., & Ealing, J. (2016). Comprehensive RNA analysis of the NF1 gene in classically affected NF1 affected individuals meeting NIH criteria has high sensitivity and mutation negative testing is reassuring in isolated cases with pigmentary features only. eBioMedicine, 7, 212–220.
Article CAS PubMed PubMed Central Google Scholar
Fahsold, R., Hoffmeyer, S., Mischung, C., Gille, C., Ehlers, C., Kücükceylan, N., Abdel-Nour, M., Gewies, A., Peters, H., Kaufmann, D. J. T. A. J., & o. H. G. (2000). Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. The American Journal of Human Genetics, 66(3), 790–818.
Article CAS PubMed Google Scholar
Farhadi-Shaheni, N., Baghbani-Arani, F., & Mahdavi-Ortakand, M. (2023). Analysis of mutable exons of neurofibromatosis type 1 (NF1) gene in Iranian patients. Feyz Medical Sciences Journal, 27(2), 939–943.
Foji, S., Dorgaleleh, S., Oladnabi, M., & Jouybari, L. (2020). NF1 Mutations analysis using whole exome sequencing technique in 11 unrelated Iranian families with neurofibromatosis type 1. International Journal of Pediatrics, 8(5), 11311–11319.
Francis, J. M., Kiezun, A., Ramos, A. H., Serra, S., Pedamallu, C. S., Qian, Z. R., Banck, M. S., Kanwar, R., Kulkarni, A. A., & Karpathakis, A. (2013). Somatic mutation of CDKN1B in small intestine neuroendocrine tumors. Nature Genetics, 45(12), 1483–1486.
Article CAS PubMed PubMed Central Google Scholar
Frayling, I. M., Mautner, V.-F., Van Minkelen, R., Kallionpaa, R. A., Aktaş, S., Baralle, D., Ben-Shachar, S., Callaway, A., Cox, H., & Eccles, D. M. (2019). Breast cancer risk in neurofibromatosis type 1 is a function of the type of NF1 gene mutation: A new genotype-phenotype correlation. Journal of Medical Genetics, 56(4), 209–219.
Article CAS PubMed Google Scholar
Gao, M., Liu, H., Sun, Q., & Yang, G. (2022). The gene diagnosis of neurofibromatosis type I with headache as the main symptom: A case report and review of the literature. Frontiers in Neurology, 13, 874613.
Article PubMed PubMed Central Google Scholar
Garcia-Linares, C., Fernández-Rodríguez, J., Terribas, E., Mercadé, J., Pros, E., Benito, L., Benavente, Y., Capella, G., Ravella, A., & Blanco, I. (2011). Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH. Human Mutation, 32(1), 78–90.
Article CAS PubMed Google Scholar
Giugliano, T., Santoro, C., Torella, A., Del Vecchio Blanco, F., Grandone, A., Onore, M. E., Melone, M. A. B., Straccia, G., Melis, D., & Piccolo, V. (2019). Clinical and genetic findings in children with neurofibromatosis type 1, Legius syndrome, and other related neurocutaneous disorders. Genes, 10(8), 580.
Article CAS PubMed PubMed Central Google Scholar
Gudmundsson, S., Singer-Berk, M., Watts, N. A., Phu, W., Goodrich, J. K., Solomonson, M., Consortium, G. A. D., Rehm, H. L., MacArthur, D. G., & O’Donnell-Luria, A. (2022). Variant interpretation using population databases: Lessons from gnomAD. Human Mutation, 43(8), 1012–1030.
Gutmann, D. H., Ferner, R. E., Listernick, R. H., Korf, B. R., Wolters, P. L., & Johnson, K. J. (2017). Neurofibromatosis type 1. Nature Reviews Disease Primers, 3(1), 1–17.
Helfferich, J., Nijmeijer, R., Brouwer, O. F., Boon, M., Fock, A., Hoving, E. W., Meijer, L., den Dunnen, W. F., & de Bont, E. S. (2016). Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas. Critical Reviews in Oncology Hematology, 104, 30–41.
Hutter, S., Piro, R. M., Waszak, S. M., Kehrer-Sawatzki, H., Friedrich, R. E., Lassaletta, A., Witt, O., Korbel, J. O., Lichter, P., & Schuhmann, M. U. (2016). No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patients. Human Genetics, 135, 469–475.
Article CAS PubMed Google Scholar
Jaganathan, K., Panagiotopoulou, S. K., McRae, J. F., Darbandi, S. F., Knowles, D., Li, Y. I., Kosmicki, J. A., Arbelaez, J., Cui, W., & Schwartz, G. B. (2019). Predicting splicing from primary sequence with deep learning. Cell, 176(3), 535-548. e524.
Article CAS PubMed Google Scholar
Jang, M., Kim, Y.-E., Kim, S. K., Lee, M.-K., Kim, J.-W., Ki, C.-S.J.J., & o. h. g. (2016). Identification and characterization of NF1 splicing mutations in Korean patients with neurofibromatosis type 1. Journal of Human Genetics, 61(8), 705–709.
Comments (0)